ClinicalTrials.gg
CompletedNCT04997109APPLES-TELEUpdated Nov 4, 2026

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

An interventional study of APPLES-tele and Parent-centered Approach (PCA) Support Intervention in Cerebral Palsy, sponsored by Emory University. Completed at 4 sites in United States. Open to participants aged 4 Months to 13 Months. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Emory University · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 4, 2026Now CompletedStudy documents posted+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
269
Allocation
Randomized
Ages
4 Months to 13 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.

Enrollment
6th of 296
269 · median 25
Started
2022
with 24 others
No phase
218 of 372
49 open now
Registered
236th of 372
by date

Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 6th largest by enrollment of the 296 interventional ones that give a count, is one of 25 that started in 2022, is one of 218 with no phase, and was the 236th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:

69 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 4 Months to 13 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Cerebral Palsy with a site in United States, or all of them as a file.
02

Study summary

This study assesses two active treatments in different sequences and a standard of care group among infants with cerebral palsy.

Read the detailed description

Cerebral palsy (CP) is a disorder characterized by impairments of sensorimotor function resulting from neural insults in the perinatal period. Every year almost 10,000 children are born with CP in the US. CP incidence ranges from 2 to 3 per 1000 in North America, Australia, and Europe and is difficult to estimate in the developing world. Intervention strategies to promote function of children with CP must be adaptable to settings where resources or access may be limited, yet simultaneously integrate best clinical evidence and neuroscientific principles. Upper extremity (UE) impairments are present in a significant portion of children with CP, some with hemiplegia (\~25% children with CP), and others with quadriplegia, in which one arm and hand may be more affected than the other (another \~25%). UE impairments in CP result from a combination of motor and sensory dysfunctions including a lack of high-quality motor experience, which combined with "noisy" (often faulty) sensory input, challenges the acquisition of new effective motor patterns.

Among the various approaches to improve UE function in infants with CP are constraint-induced movement therapy (the use of constraints on less affected limbs) and bimanual therapy (training of both extremities in coordination). Brief sessions of parent-delivered, infant-initiated, goal-directed, success-motivated and repetitive activity in enriched sensory environments can be effective, while respecting fundamental principles of infant development and home life. Parent administration of the intervention helps preserve the integrity of early parent-child relationships, critical to establishment of infants' sense of self, safety, and independence.

Finally, to take full advantage of neuroplasticity and maximize potential downstream developmental effects, it is essential to intervene as early as possible in children with CP. Promising new treatments such as transcranial magnetic stimulation, robotic-assisted movements and technology enhancements to movement feedback are in development. However, these interventions require substantial investments of highly-skilled therapists, technology, infrastructure and access to academic facilities. While the new interventions advance the cutting-edge of motor intervention development, on another leading edge, parent-delivered therapist-directed telehealth interventions are becoming more widespread, addressing a critical need for lower-resource interventions.

Healthcare systems resources are limited, and can be difficult to access due to geographic and socioeconomic obstacles. While telehealth therapy seems eminently practical, and a natural extension of current interventions for infants with CP, it faces its own scientific challenges. The same essential attributes of physical therapy that make it so effective in person can make it difficult to deliver via telehealth. Telehealth therapy in infants requires a level of parent engagement, knowledge and parenting skills that is sometimes lacking. Feasible telehealth interventions to improve function in infants with CP must also address the challenges faced by their parents in conducting the sessions through effective parenting supports.

In this study, infant participants with CP will be randomized to one of three treatment groups:

  1. The APPLES intervention via telehealth (APPLES-tele) followed by a parent-centered approach (PCA) intervention
  2. The PCA intervention followed by the APPLES-tele intervention
  3. The standard of care

Outcome measures will be standardized assessments of hand/arm function and validated parent-report measures of infant motor activity.

03

Conditions studied

  • Cerebral Palsy

Browse trials for

04

Who can participate

Ages eligible
4 Months to 13 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 4 to 13 months, corrected age
  • Diagnosis of CP or classification of high-risk for CP as determined by published guidelines (>95% risk of later CP)
  • Hammersmith Infant Neurological Exam (HINE) arm asymmetry score of greater than or equal to 2 and/or neuroimaging consistent with perinatal involvement
  • Hand Assessment for Infants (HAI) difference between hands ≥2, with an observable and relative difference in quality or amount of movement between hands, as determined by HAI-certified study therapists and/or a unimanual Bayley score difference between hands >1
  • Parent/legal guardian is able to provide

Exclusion criteria

Exclusion Criteria:

  • Congenital malformation of the brain or musculoskeletal system (MSK)
  • Receipt of botulinum toxin to the affected extremity within 3 months of study entry
  • Any prior long-term hard constraint programs
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
269 participants (actual)

Study arms

  • Experimental
    APPLES-tele first, then PCA

    Participants receiving the APPLES-tele intervention for 6 weeks followed by the PCA intervention for 6 weeks.

    Other: APPLES-tele · Behavioral: Parent-centered Approach (PCA) Support Intervention

  • Experimental
    PCA first, then APPLES-tele

    Participants receiving the PCA intervention for 6 weeks followed by the APPLES-tele intervention for 6 weeks.

    Other: APPLES-tele · Behavioral: Parent-centered Approach (PCA) Support Intervention

  • Active comparator
    Standard of Care Control Arm

    Participants receiving the standard of care for 6 weeks.

    Behavioral: Standard of Care

Interventions

  • OtherAPPLES-tele

    The APPLES-tele intervention is 5 weekly telehealth sessions of therapist-demonstrated tasks, delivered over a 6 week period. Infant participants wear a soft-constraint harness (C-Mitt) on their less affected arm for 6 hours per day, while their parent encourages them to use their more affected arm to complete play-based activities as instructed by the study therapist. As the infant experiences success, heavier objects are provided. During times when the C-Mitt is not worn, parents engage therapist-demonstrated bimanual play of increasing difficulty.

    Also known as: C-Mitt

  • BehavioralParent-centered Approach (PCA) Support Intervention

    The PCA support intervention is 5 weekly telehealth sessions delivered over a 6 week period. The PCA curriculum includes 5 basic principles of positive parenting from Triple P: ensuring a safe engaging environment, creating a positive learning environment, using assertive discipline, having reasonable expectations, and looking after yourself as a parent. All of these elements, when taught to parents in an individualized manner, can help promote responsivity, structure and expectations that are tailored to their child's condition and developmental stage. In addition, a curriculum of CP-specific knowledge will address the challenges unique to parents of children with CP, such as understanding principles of infant learning of new movements, challenges and solutions for self-directed activity in infants with CP.

  • BehavioralStandard of Care

    Participants will receive the usual care from being followed in high-risk infant follow-up (HRIF) programs in the Early Detection and Intervention (EDI) Network.

06

What researchers measure

Primary outcomes

  1. Bayley Scales of Infant and Toddler Development (Bayley-3) More Affected Arm Motor Function Score

    The Bayley-3 instrument is a norm-referenced test assessing developmental delays in early childhood. The fine motor function of the more affected upper extremity is assessed using the 54 unimanual items of the Bayley-3 instrument. Responses are provided on a 3-point scale where 0 = the skill is not present, 1 = the skill is emerging, and 2 = the skill is mastered. Total unimanual fine motor raw scores for the more affected arm range from 0 to 108 where higher scores indicate greater fine motor function.

    Time frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)

  2. Parenting Styles and Dimensions Questionnaire (PSDQ) Authoritative Scale Score

    The Authoritative Parenting Style scale of the Parenting Styles and Dimensions Questionnaire (PSDQ) - short version, includes 15 items that are rated on a 5-point scale where 1 = never and 5 = always. The raw score ranges from 15 to 75 and higher scores indicate a more expression of the authoritative parenting style.

    Time frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)

Secondary outcomes

  1. Infant Motor Activity Log (IMAL) How Often Score

    Parent perception of hand performance is assessed with the IMAL. The IMAL includes 20 items asking caregivers how often and how well the infant uses their less preferred hand. Responses are given on a 5-point Likert scale where 0 = not used and 5 = normal use. Raw scores on how often the infant uses their less preferred hand range from 0 to 100, with higher scores indicating more normal hand usage.

    Time frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)

  2. Hand Assessment in Infants (HAI) Score

    The HAI is an assessment evaluating quality and frequency of hand abilities in infants 3 to 12 months corrected age using a semi-structured 12-15 min videotaped play session that is scored by a certified therapist. There are 12 unimanual and 5 bimanual items, each is scored on a 3-point rating scale, of 0, 1, or 2 points. Each hand receives a raw score based upon performance on the unimanual items. The raw score for the more affected hand will be reported as a continuous variable. Total raw scores for the unimanual items range from 0 to 24 and higher scores indicate greater ability.

    Time frame: Baseline, Week 6 (after the first intervention)

  3. Bayley Scales of Infant and Toddler Development (Bayley-3) Global Fine Motor Function Score

    The Bayley-3 instrument is a norm-referenced test assessing developmental delays in early childhood. The fine motor function scale of the Bayley-3 instrument includes 66 items, and responses are provided on a 3-point scale where 0 = the skill is not present, 1 = the skill is emerging, and 2 = the skill is mastered. Total fine motor raw scores range from 0 to 132 where higher scores indicate greater fine motor function.

    Time frame: Baseline, Week 6 (after the first intervention)

  4. Welch Emotional Connection Screen (WECS) Score

    The WECS assesses parent-infant connection by examining four emotional connection dimensions of behavior: attraction, vocal communication, facial communication, and sensitivity. Items are rated on a 3-point scale where 1 = low and 3 = high. A WECS Mother (WECS-M) score is created by summing the four items for maternal connection while the four items for infant connection create a WECS Infant (WECS-I) score. Total WECS-M or WECS-I scores range from 4 to 12 where higher scores indicate greater connection.

    Time frame: Baseline, Week 6 (after the first intervention)

  5. Maternal Confidence Questionnaire (MCQ) Score

    The MCQ assesses parent knowledge and confidence in caring for and understanding their infant. The MCQ has 14 items which are scored on a 5-point scale where 1 = never and 5 = a great deal. Scores are reversed for some items and total scores range from 14 to 70. Higher scores indicate greater maternal confidence.

    Time frame: Baseline, Week 6 (after the first intervention)

07

Study locations

4 sites
  • Emory University
    Atlanta, Georgia 30322, United States
  • Kennedy Krieger Institute
    Baltimore, Maryland 21205, United States
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania 19104, United States
  • The University of Utah
    Salt Lake City, Utah 84112, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2022 to primary completion in Oct 2026, 55 months.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 55 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Aug 2026 → Oct 2026 and completion Feb 2027 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2021
First posted
Aug 9, 2021
StartActual
Feb 23, 2022
Primary completionActual
Oct 12, 2026was Aug 2026
CompletionActual
Oct 12, 2026was Feb 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 4, 2026
Primary completion
Aug 31, 2026→Oct 12, 2026 (actual)
Nov 4, 2026
Study completion
Feb 28, 2027→Oct 12, 2026 (actual)
Nov 4, 2026
Enrollment
267 (estimated)→269 (actual)
Nov 4, 2026
Primary outcomes
2 edited
What changed in the outcomes
  • EditedChange in Bayley Scales of Infant and Toddler Development (Bayley-3) More Affected Arm Motor Function ScoreTime frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)
  • EditedChange in Parenting Styles and Dimensions Questionnaire (PSDQ) Authoritative Scale ScoreTime frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)
Nov 4, 2026
Documents
Nov 4, 2026
Secondary outcomes
5 edited
What changed in the outcomes
  • EditedChange in Infant Motor Activity Log (IMAL) How Often ScoreTime frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)
  • EditedChange in Hand Assessment in Infants (HAI) ScoreTime frame: Baseline, Week 6 (after the first intervention)
  • EditedChange in Bayley Scales of Infant and Toddler Development (Bayley-3) Global Fine Motor Function ScoreTime frame: Baseline, Week 6 (after the first intervention)
  • EditedChange in Welch Emotional Connection Screen (WECS) ScoreTime frame: Baseline, Week 6 (after the first intervention)
  • EditedChange in Maternal Confidence Questionnaire (MCQ) ScoreTime frame: Baseline, Week 6 (after the first intervention)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Recruiting→Completed
    Documents Informed consent form ↗ posted
    Primary completion Aug 31, 2026→Oct 12, 2026 (now actual)
    Study completion Feb 28, 2027→Oct 12, 2026 (now actual)
    Enrollment 267 (estimated)→269 (actual)
    Primary outcomes 2 edited
    What changed in the outcomes
    • EditedChange in Bayley Scales of Infant and Toddler Development (Bayley-3) More Affected Arm Motor Function ScoreTime frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)
    • EditedChange in Parenting Styles and Dimensions Questionnaire (PSDQ) Authoritative Scale ScoreTime frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)
    Secondary outcomes 5 edited
    What changed in the outcomes
    • EditedChange in Infant Motor Activity Log (IMAL) How Often ScoreTime frame: Baseline, Week 6 (after the first intervention), Week 12 (after the second intervention)
    • EditedChange in Hand Assessment in Infants (HAI) ScoreTime frame: Baseline, Week 6 (after the first intervention)
    • EditedChange in Bayley Scales of Infant and Toddler Development (Bayley-3) Global Fine Motor Function ScoreTime frame: Baseline, Week 6 (after the first intervention)
    • EditedChange in Welch Emotional Connection Screen (WECS) ScoreTime frame: Baseline, Week 6 (after the first intervention)
    • EditedChange in Maternal Confidence Questionnaire (MCQ) ScoreTime frame: Baseline, Week 6 (after the first intervention)
    + 5 other changes: identifiers, verification date, oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04997109
Lead sponsor
Emory University
Responsible party
Nathalie Maitre (Professor, Emory University) — Principal investigator
First posted
Aug 9, 2021
Start date
Feb 23, 2022
Primary completion
Oct 12, 2026
Completion
Oct 12, 2026
Last update
Nov 4, 2026

Study contacts

Nathalie Maitre, MD, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion